What are the major opportunities in the Sylvant (Siltuximab) market? What are the strategies for the Sylvant (Siltuximab) market?

For detailed insights on the major opportunities and strategies in the Sylvant (Siltuximab) market, Read More

How does the Sylvant (Siltuximab) market relate to the overall economy and other similar markets?

For detailed insights on Sylvant (Siltuximab)'s relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Sylvant (Siltuximab) industry?

For detailed insights on the mergers and acquisitions in the Sylvant (Siltuximab) industry, Read More

What are the key dynamics influencing the Sylvant (Siltuximab) market growth? SWOT analysis of the Sylvant (Siltuximab) market.

For detailed insights on the key dynamics influencing the Sylvant (Siltuximab) market growth and SWOT analysis of the Sylvant (Siltuximab) industry, Read More

Sylvant (Siltuximab) Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : January 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Sylvant (Siltuximab) Market Report 2026

Name: Sylvant (Siltuximab) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Indication (Multicentric Castleman Disease (MCD), Human Immunodeficiency Virus (HIV)-Associated Multicentric Castleman Disease (MCD), Non-Hodgkin Lymphoma (NHL)), By Application (Injections, Vials, Lyophilized Powder, Solution For Infusion, Prefilled Syringes), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Home Care) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Sylvant (Siltuximab) Market Overview

• The Sylvant (Siltuximab) market growth in the historic period has been driven by increased diagnosis of multicentric castleman disease, improved awareness of cytokine-driven disorders

• Market expansion is supported by increasing exploration of additional inflammatory indications, rising demand for precision immunotherapy solutions

• Growth Driver: Rising Prevalence Of Multicentric Castleman Disease (MCD) Driving Growth Of The Market

• Market Trend: Innovative Monoclonal Antibody Therapies Transform MCD Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Sylvant (Siltuximab) Market?

Sylvant (siltuximab) is a monoclonal antibody that targets and neutralizes interleukin-6 (IL-6), a cytokine involved in inflammation and immune responses. By inhibiting IL-6, it helps reduce inflammation and regulate immune activity, particularly in conditions such as multicentric castleman's disease (MCD). It is used to manage MCD symptoms, improve quality of life, and slow disease progression.

The main types of indication for sylvant (siltuximab) are multicentric castleman disease (MCD), human immunodeficiency virus (HIV)-associated multicentric castleman disease (MCD), and non-Hodgkin lymphoma (NHL). Multicentric castleman disease (MCD) is a rare immune disorder causing lymphoid tissue overgrowth, and Sylvant (Siltuximab) treats it by targeting specific proteins to reduce inflammation and improve outcomes. It is used for several applications, such as injections, vials, lyophilized powder, solutions for infusion, and prefilled syringes, and is used by various end users, including hospitals, specialty clinics, ambulatory surgical centers (ASCs), and home care.

Sylvant (Siltuximab) Market Global Report 2026 Market Report bar graph

What Is The Sylvant (Siltuximab) Market Size and Share 2026?

The growth in the historic period can be attributed to increased diagnosis of multicentric castleman disease, improved awareness of cytokine-driven disorders, expansion of specialty oncology and immunology centers, advances in monoclonal antibody development, growing clinical use of targeted biologics.

What Is The Sylvant (Siltuximab) Market Growth Forecast?

The growth in the forecast period can be attributed to increasing exploration of additional inflammatory indications, rising demand for precision immunotherapy solutions, advancements in biologic drug formulation, expansion of specialty clinic networks, improved global access to rare disease treatments. Major trends in the forecast period include increasing adoption of targeted il-6 inhibitor therapies, growing use in rare immunological disorders, expansion of monoclonal antibody treatment protocols, enhanced focus on inflammatory pathway modulation, improved patient outcome monitoring.

Book your 30 minutes free consultation with our research experts

Global Sylvant (Siltuximab) Market Segmentation

1) By Indication: Multicentric Castleman Disease (MCD), Human Immunodeficiency Virus (HIV)-Associated Multicentric Castleman Disease (MCD), Non-Hodgkin Lymphoma (NHL)

2) By Application: Injections, Vials, Lyophilized Powder, Solution For Infusion, Prefilled Syringes

3) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Home Care

What Are The Drivers Of The Sylvant (Siltuximab) Market?

The increasing prevalence of multicentric castleman disease (MCD) is significantly driving the growth of the sylvant (siltuximab) market in the future. Multicentric castleman disease (MCD) is a rare condition involving the abnormal enlargement of lymph nodes and tissues, commonly linked to inflammation and immune system abnormalities. The rising cases of multicentric castleman disease (MCD) are attributed to factors such as improved diagnosis, greater awareness, and advancements in medical imaging. Sylvant (siltuximab) works by targeting and blocking interleukin-6 (IL-6), a cytokine that contributes to inflammation and disease progression in MCD. This inhibition helps reduce inflammation and control the abnormal growth of lymph nodes and tissues, offering an effective treatment for MCD patients. For instance, in February 2025, according to the Consult QD, a US-based medical news and education platform, the only FDA-approved treatment for this condition was used in just 22% of patients. This reveals a significant unmet treatment need, considering this is the only FDA-approved drug for iMCD in the U.S. Therefore, increasing prevalence of multicentric castleman disease (MCD) is driving the growth of the sylvant (siltuximab) industry.

The shifting focus toward precision medicine is expected to propel the growth of the sylvant (siltuximab) market going forward. Precision medicine is a healthcare approach that customizes treatments based on a person's unique genetic makeup, environment, and lifestyle. The demand for precision medicine is rising due to advancements in genetic research, increasing prevalence of personalized healthcare, and growing adoption of targeted therapies. Sylvant (siltuximab) targets and inhibits interleukin-6 (IL-6), a cytokine involved in inflammation and disease progression. By specifically addressing elevated IL-6 levels in patients with multicentric castleman disease (MCD), it offers a more personalized and more effective treatment compared to standard therapies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the shifting focus toward precision medicine is driving the growth of the sylvant (siltuximab) industry.

Key Players In The Global Sylvant (Siltuximab) Market

Major companies operating in the sylvant (siltuximab) market are Recordati Rare Diseases Inc.

Global Sylvant (Siltuximab) Market Trends and Insights

Major companies operating in the Sylvant (Siltuximab) market are focusing on developing innovative solutions, such as monoclonal antibody therapies, to meet the rising demand for targeted treatment options for multicentric Castleman disease (MCD). Monoclonal antibody therapies are designed to specifically bind to disease-associated proteins, helping modulate immune responses and improve patient outcomes compared to conventional treatments. For instance, in September 2024, the European Commission, a Belgium-based executive body of the European Union responsible for proposing and enforcing EU policies and legislation, approved SYLVANT (siltuximab) as a treatment for MCD. SYLVANT is a monoclonal antibody that binds to interleukin-6 (IL-6), inhibiting its activity, which helps reduce inflammation and disease symptoms. This therapy provides a targeted, non-chemotherapy option for patients with MCD.

Need data on a specific region in this market?

Request Regional Data

Regional Insights

North America was the largest region in the sylvant (siltuximab) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Sylvant (Siltuximab) Market?

The sylvant (siltuximab) market consists of sales of oral dosage forms, compounded solutions, and intravenous (IV) infusion bags. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Sylvant (Siltuximab) Market Report 2026?

The sylvant (siltuximab) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sylvant (siltuximab) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Sylvant (Siltuximab) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$ billion
Revenue Forecast In 2035	$ billion
Growth Rate	No CAGR found from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Indication, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Recordati Rare Diseases Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Sylvant (Siltuximab) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Sylvant (Siltuximab) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Sylvant (Siltuximab) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Sylvant (Siltuximab) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics And Precision Medicine

4.1.2 Artificial Intelligence And Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data And Cybersecurity

4.1.4 Industry 4.0 And Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech And Circular Economy

4.2. Major Trends

4.2.1 Increasing Adoption Of Targeted Il-6 Inhibitor Therapies

4.2.2 Growing Use In Rare Immunological Disorders

4.2.3 Expansion Of Monoclonal Antibody Treatment Protocols

4.2.4 Enhanced Focus On Inflammatory Pathway Modulation

4.2.5 Improved Patient Outcome Monitoring

5. Sylvant (Siltuximab) Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Oncology Centers

5.4 Immunology Clinics

5.5 Ambulatory Surgical Centers

6. Sylvant (Siltuximab) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Sylvant (Siltuximab) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Sylvant (Siltuximab) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Sylvant (Siltuximab) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Sylvant (Siltuximab) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Sylvant (Siltuximab) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Sylvant (Siltuximab) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Sylvant (Siltuximab) Market Segmentation

9.1. Global Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Multicentric Castleman Disease (MCD), Human Immunodeficiency Virus (HIV)-Associated Multicentric Castleman Disease (MCD), Non-Hodgkin Lymphoma (NHL)

9.2. Global Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injections, Vials, Lyophilized Powder, Solution For Infusion, Prefilled Syringes

9.3. Global Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Home Care

10. Sylvant (Siltuximab) Market Regional And Country Analysis

10.1. Global Sylvant (Siltuximab) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Sylvant (Siltuximab) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Sylvant (Siltuximab) Market

11.1. Asia-Pacific Sylvant (Siltuximab) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Sylvant (Siltuximab) Market, Segmentation By Indication, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Sylvant (Siltuximab) Market

12.1. China Sylvant (Siltuximab) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Sylvant (Siltuximab) Market, Segmentation By Indication, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Sylvant (Siltuximab) Market

13.1. India Sylvant (Siltuximab) Market, Segmentation By Indication, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Sylvant (Siltuximab) Market

14.1. Japan Sylvant (Siltuximab) Market Overview

14.2. Japan Sylvant (Siltuximab) Market, Segmentation By Indication, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Sylvant (Siltuximab) Market

15.1. Australia Sylvant (Siltuximab) Market, Segmentation By Indication, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Sylvant (Siltuximab) Market

16.1. South Korea Sylvant (Siltuximab) Market Overview

16.2. South Korea Sylvant (Siltuximab) Market, Segmentation By Indication, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Sylvant (Siltuximab) Market

17.1. Western Europe Sylvant (Siltuximab) Market Overview

17.2. Western Europe Sylvant (Siltuximab) Market, Segmentation By Indication, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Sylvant (Siltuximab) Market

18.1. UK Sylvant (Siltuximab) Market, Segmentation By Indication, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Sylvant (Siltuximab) Market

19.1. Germany Sylvant (Siltuximab) Market, Segmentation By Indication, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Sylvant (Siltuximab) Market

20.1. France Sylvant (Siltuximab) Market, Segmentation By Indication, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Sylvant (Siltuximab) Market

21.1. Eastern Europe Sylvant (Siltuximab) Market Overview

21.2. Eastern Europe Sylvant (Siltuximab) Market, Segmentation By Indication, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Sylvant (Siltuximab) Market

22.1. North America Sylvant (Siltuximab) Market Overview

22.2. North America Sylvant (Siltuximab) Market, Segmentation By Indication, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Sylvant (Siltuximab) Market

23.1. USA Sylvant (Siltuximab) Market Overview

23.2. USA Sylvant (Siltuximab) Market, Segmentation By Indication, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Sylvant (Siltuximab) Market

24.1. Canada Sylvant (Siltuximab) Market Overview

24.2. Canada Sylvant (Siltuximab) Market, Segmentation By Indication, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Sylvant (Siltuximab) Market

25.1. South America Sylvant (Siltuximab) Market Overview

25.2. South America Sylvant (Siltuximab) Market, Segmentation By Indication, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Sylvant (Siltuximab) Market

26.1. Middle East Sylvant (Siltuximab) Market Overview

26.2. Middle East Sylvant (Siltuximab) Market, Segmentation By Indication, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Sylvant (Siltuximab) Market

27.1. Africa Sylvant (Siltuximab) Market Overview

27.2. Africa Sylvant (Siltuximab) Market, Segmentation By Indication, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Sylvant (Siltuximab) Market Regulatory and Investment Landscape

29. Sylvant (Siltuximab) Market Competitive Landscape And Company Profiles

29.1. Sylvant (Siltuximab) Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Sylvant (Siltuximab) Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Sylvant (Siltuximab) Market Company Profiles

29.3.1. Recordati Rare Diseases Inc. Overview, Products and Services, Strategy and Financial Analysis

30. Global Sylvant (Siltuximab) Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Sylvant (Siltuximab) Market

32. Sylvant (Siltuximab) Market High Potential Countries, Segments and Strategies

32.1 Sylvant (Siltuximab) Market In 2030 - Countries Offering Most New Opportunities

32.2 Sylvant (Siltuximab) Market In 2030 - Segments Offering Most New Opportunities

32.3 Sylvant (Siltuximab) Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Sylvant (Siltuximab) Market, Overview Of Key Products - Product Examples

Table 2: Global Sylvant (Siltuximab) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Sylvant (Siltuximab) Market, Supply Chain Analysis

Table 4: Global Sylvant (Siltuximab) Market, Major Raw Material Providers

Table 5: Global Sylvant (Siltuximab) Market, Major Resource Providers

Table 6: Global Sylvant (Siltuximab) Market, Major Manufacturers (Suppliers)

Table 7: Global Sylvant (Siltuximab) Market, Major Distributors And Channel Partners

Table 8: Global Sylvant (Siltuximab) Market, Key Technologies & Future Trends

Table 9: Global Sylvant (Siltuximab) Market, Major Trends

Table 10: Global Sylvant (Siltuximab) Market, Major End Users

Table 11: Global Sylvant (Siltuximab) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Sylvant (Siltuximab) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Sylvant (Siltuximab) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Sylvant (Siltuximab) Market - TAM, US$ Billion, 2025

Table 15: Global Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Sylvant (Siltuximab) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Sylvant (Siltuximab) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Asia-Pacific, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Asia-Pacific, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: China, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: China, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: India, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: India, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Japan, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Japan, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Australia, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Australia, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: South Korea, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: South Korea, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: South Korea, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Western Europe, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Western Europe, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Western Europe, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: UK, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: UK, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: UK, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Germany, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Germany, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Germany, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: France, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: France, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: France, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Eastern Europe, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Eastern Europe, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Eastern Europe, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: North America, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: North America, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: North America, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: USA, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: USA, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: USA, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Canada, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Canada, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Canada, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: South America, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: South America, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: South America, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Middle East, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Middle East, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Middle East, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Africa, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Africa, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Africa, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Global Sylvant (Siltuximab) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 72: Global Sylvant (Siltuximab) Market - Company Scoring Matrix

Table 73: Recordati Rare Diseases Inc. Financial Performance

Table 74: Global Sylvant (Siltuximab) Market, Competitive Benchmarking (In USD Billions)

Table 75: Global Sylvant (Siltuximab) Market, Competitive Dashboard

Table 76: Global Sylvant (Siltuximab) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 77: Global, Sylvant (Siltuximab) Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Table 78: Global, Sylvant (Siltuximab) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 79: Global, Sylvant (Siltuximab) Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

Figure 1: Global Sylvant (Siltuximab) Market, Overview Of Key Products - Product Examples

Figure 2: Global Sylvant (Siltuximab) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Sylvant (Siltuximab) Market, Supply Chain Analysis

Figure 4: Global Sylvant (Siltuximab) Market, Major Raw Material Providers

Figure 5: Global Sylvant (Siltuximab) Market, Major Resource Providers

Figure 6: Global Sylvant (Siltuximab) Market, Major Manufacturers (Suppliers)

Figure 7: Global Sylvant (Siltuximab) Market, Major Distributors And Channel Partners

Figure 8: Global Sylvant (Siltuximab) Market, Key Technologies & Future Trends

Figure 9: Global Sylvant (Siltuximab) Market, Major Trends

Figure 10: Global Sylvant (Siltuximab) Market, Major End Users

Figure 11: Global Sylvant (Siltuximab) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Sylvant (Siltuximab) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Sylvant (Siltuximab) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Sylvant (Siltuximab) Market - TAM, US$ Billion, 2025

Figure 15: Global Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Sylvant (Siltuximab) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Sylvant (Siltuximab) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Asia-Pacific, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Asia-Pacific, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: China, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: China, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: India, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: India, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Japan, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Japan, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Australia, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Australia, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: South Korea, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: South Korea, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: South Korea, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Western Europe, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Western Europe, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Western Europe, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: UK, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: UK, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: UK, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Germany, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Germany, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Germany, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: France, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: France, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: France, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Eastern Europe, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Eastern Europe, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Eastern Europe, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: North America, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: North America, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: North America, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: USA, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: USA, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: USA, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Canada, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Canada, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Canada, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: South America, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: South America, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: South America, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Middle East, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Middle East, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Middle East, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Africa, Sylvant (Siltuximab) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Africa, Sylvant (Siltuximab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Africa, Sylvant (Siltuximab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Global Sylvant (Siltuximab) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 72: Global Sylvant (Siltuximab) Market - Company Scoring Matrix

Figure 73: Recordati Rare Diseases Inc. Financial Performance

Figure 74: Global Sylvant (Siltuximab) Market, Competitive Benchmarking (In USD Billions)

Figure 75: Global Sylvant (Siltuximab) Market, Competitive Dashboard

Figure 76: Global Sylvant (Siltuximab) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 77: Global, Sylvant (Siltuximab) Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Figure 78: Global, Sylvant (Siltuximab) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 79: Global, Sylvant (Siltuximab) Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Competitive and Market Trend Analysis of Gastric Cancer Therapy Industry Through 2029

Industry Trends Show Gastrointestinal Therapeutics Market Set to Expand at 5.5% CAGR Until 2029

Key Market Drivers, Trends, and Forecast for the Global Gene-Editing Transfection Chemicals Industry

Outlook for Generic Pharmaceuticals Contract Manufacturing Market: Key Developments and Future Strategies to 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Antibody Contract Manufacturing Market Report 2026 - Global Outlook – By Product (Monoclonal Antibodies, Polyclonal Antibodies, Other Products), By Source (Mammalian, Microbial), By Scale Of Operation (Preclinical, Clini...

Next-Generation Antibody Therapeutics Market Report 2026 - Global Outlook – By Types Of Antibodies (Monoclonal Antibodies, Polyclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates, Other Types), By Therapeu...

Antibody Discovery Market Report 2026 - Global Outlook – By Methods (Phage Display, Hybridoma, Other Methods), By Antibody Type (Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody), By End Users (Phar...

Cell Therapy Market Report 2026 - Global Outlook – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy ), By Therapy Type (Allogeneic Therapies, ...

Anemia And Other Blood Disorder Drugs Market Report 2026 - Global Outlook – By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia ), By Route of Administration (Oral, Injecta...

Hematology Drugs Market 2022 - By Type (Hemophilia, Anemia, Blood Products, Other Blood Disorder Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Pa...

G-CSF (Granulocyte Colony Stimulating Factors) Market 2021 - By Type (Pegfilgrastim, Filgrastim, Lenograstim), By Application (Oncology, Blood Disorders, Chronic and Autoimmune Disorders), And By Region, Opportunities An...

Frequently Asked Questions

What is the projected market size of the Sylvant (Siltuximab) Market Report 2026 market by 2030?

The Sylvant (Siltuximab) Market Report 2026 market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030. request a sample here

What is the expected CAGR for the Sylvant (Siltuximab) Market Report 2026 market during the forecast period 2025 - 2030?

The expected CAGR for the Sylvant (Siltuximab) Market Report 2026 market during the forecast period 2025–2030 is %. request a sample here

What are the key factors driving the Sylvant (Siltuximab) Market Report 2026 market?

Major growth driver of the market includes: Rising Prevalence Of Multicentric Castleman Disease (MCD) Driving Growth Of The Market in the Sylvant (Siltuximab) Market Report 2026 market. For further insights on this market, request a sample here

Which end-use segment are covered in the Sylvant (Siltuximab) Market Report 2026 market report?

The sylvant (siltuximab) market covered in this report is segmented –
1) By Indication: Multicentric Castleman Disease (MCD), Human Immunodeficiency Virus (HIV)-Associated Multicentric Castleman Disease (MCD), Non-Hodgkin Lymphoma (NHL)
2) By Application: Injections, Vials, Lyophilized Powder, Solution For Infusion, Prefilled Syringes
3) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Home Care request a sample here

What is the anticipated growth trend for the Sylvant (Siltuximab) Market Report 2026 market?

Major trend in this market includes: Innovative Monoclonal Antibody Therapies Transform MCD Treatment For further insights on this market, request a sample here.

Who are the key players in the Sylvant (Siltuximab) Market Report 2026 market?

Major companies operating in the Sylvant (Siltuximab) Market Report 2026 market are Major companies operating in the sylvant (siltuximab) market are Recordati Rare Diseases Inc. request a sample here.

Which region has the most growth potential in the Sylvant (Siltuximab) Market Report 2026 market?

North America was the largest region in the sylvant (siltuximab) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sylvant (siltuximab) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.